[Treatment for coronary artery disease patients with impaired glucose tolerance].
Kume
Atsumi
A
Department of Cardiology, Juntendo University School of Medicine.
Miyazaki
Tetsuro
T
Daida
Hiroyuki
H
D020909:Acarbose / Q000627:therapeutic use; D001645:Biguanides / Q000627:therapeutic use; D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000209:etiology* / Q000517:prevention & control / Q000628:therapy*; D018149:Glucose Intolerance / Q000150:complications* / Q000503:physiopathology / Q000628:therapy; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007333:Insulin Resistance; D008019:Life Style; D008687:Metformin / Q000627:therapeutic use; D012306:Risk; D045162:Thiazolidinediones / Q000627:therapeutic use
D001645:Biguanides; D065089:Glycoside Hydrolase Inhibitors; D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D008687:Metformin; D020909:Acarbose